Because FCGR2A and CD163 were significantly increased in HLH-malignancy (Fig. 4o–q), we explored the AUCs of these two proteins for distinguishing HLH-malignancy and other types of HLH. The gene discussed is FCGR2A; the disease is hemophagocytic syndrome.